Organization Profile

You just read:

Aeterna Zentaris Reports Updated Phase 1 Trial Results for AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer at ASCO GCS Meeting

News provided by

Aeterna Zentaris Inc.

Feb 03, 2012, 07:37 ET